Analyst Firm Ranks Oracle as Leader in Customer Relationship Management
Applications for the Life Sciences Industry
Oracle Strikes the Right Balance Between Industry Specificity and
Functionality According to Datamonitor
REDWOOD SHORES, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Oracle today
announced that Datamonitor, a leading provider of online data, analytic and
forecasting platforms for key vertical sectors, has recognized Oracle as a
leader in customer relationship management (CRM) applications for the life
sciences industry. According to Datamonitor's Decision Matrix: Selecting a
CRM Vendor in the Pharmaceutical Industry (Competitor Focus), Oracle combines
robust CRM technology with extensive market impact in the pharmaceutical
sector.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020718/ORCLLOGO)
According to the report, Oracle is recognized as the leading vendor in the
categories of market impact, technology assessment and end-user sentiment,
which propels it to a top position on the shortlist of CRM vendors in the
pharmaceutical industry. In addition, the report - which also evaluated
Cegedim Dendrite, Salesforce.com, StayinFront and Verticals onDemand - rates
Oracle's Siebel CRM as the most recognized solution among surveyed respondents
and the solution that received the highest scores across six out of eight
end-user categories, including product quality, portfolio depth and financial
stability.
"Because Siebel CRM 8 balances industry expertise with a robust
enterprise-class technology that is customizable to every type of end user in
pharmaceutical sales and marketing, life science companies should shortlist
Oracle when considering a CRM product," wrote Markella Kordoyanni, Datamonitor
analyst for Pharmaceutical Technology, and Nicole Engelbert, Datamonitor lead
analyst for Vertical Markets Technology, in the report. "Siebel CRM 8 is a
harmonious fit for companies looking for enterprise-wide, global deployment of
a comprehensive 'out-of-the-box' solution that offers a 360-degree view if its
customers," the report continues.
"Oracle understands the value of tailoring our applications to the
distinct industries we serve. This is particularly important in the life
sciences industry, which faces a set of unique competitive and regulatory
challenges," said Neil de Crescenzo, group vice president, Healthcare and Life
Sciences, Oracle. "Datamonitor's Decision Matrix for CRM in the
pharmaceutical industry - along with the fact that 20 of the top 20 life
sciences organizations run Oracle applications - underscores Oracle's
commitment to and success in delivering industry-specific functionality to our
life sciences customers."
Study Methodology
The Decision Matrix report provides guidance and recommendations for
companies planning to implement a CRM solution - positioning vendors in one of
three categories: 1) shortlist - defined in the report as vendors with an
established, commanding market position with a product that is widely accepted
as best of breed; 2) consider - defined as vendors that offer competitive
functionality and high performance at affordable costs, and should be
considered as part of the technology selection process; and 3) explore -
defined as vendors with less broad applicability and limited functionality
that may meet specific requirements.
To provide a comprehensive view of the competitive landscape of CRM
solutions, Datamonitor surveyed nearly 300 end users in the pharmaceutical
industry. The research provider also conducted in-depth briefings with the
vendors profiled in the report and used secondary research sources to provide
information and validate the report.
To view a summary of Datamonitor's Decision Matrix: Selecting a CRM Vendor
in the Pharmaceutical Industry (Competitor Focus), visit
http://www.oracle.com/corporate/analyst/reports/ent_apps/crm/datamonitor-crm-
pharmaceutical.pdf. The full report is available for purchase at
http://www.Datamonitor.com
(Report Code DMTC 2133).
About Oracle
Oracle (Nasdaq: ORCL) is the world's largest enterprise software company.
For more information about Oracle, visit our Web site at
http://www.oracle.com.
Trademarks
Oracle is a registered trademark of Oracle Corporation and/or its
affiliates. Other names may be trademarks of their respective owners.
Reference herein to third party content, including analysis, opinions,
predictions and statements, does not constitute or imply Oracle's endorsement
of or concurrence with such content.
SOURCE Oracle Corporation
Carol Sato of Oracle, +1-650-633-5551, carol.sato@oracle.com; or Mary Tobin of
O'Keeffe & Company, +1-503-658-7396, mtobin@okco.com
